• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗神经肿瘤学研究与实践概述:NOSC倡议实施三年情况

An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.

作者信息

Haddad Peiman, Shazadi Sohrab, Samiei Farhad, Kharrazi Homayoun Hadizadeh, Tabatabaeefar Morteza, Rakhsha Afshin, Faranoosh Mohammad, Torabi-Nami Mohammad, Dadras Ali, Liaghi Atieh, Nafarieh Leila

机构信息

Cancer Institute, Department of Radiation Oncology, School of Medicine, Tehran University of Medical Sciences Tehran, Iran.

Department of Neurosurgery, School of Medicine, Shahid Beheshti University of Medical Sciences Tehran, Iran.

出版信息

Int J Clin Exp Med. 2015 Mar 15;8(3):3946-55. eCollection 2015.

PMID:26064296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4443130/
Abstract

Research and practice of neuro-oncology compiles clinical neuroscience expertise from neurosurgery, radiation oncology, neuroradiology, medical oncology, neuropathology and related disciplines to optimize planning and therapy in central nervous system malignancies. Such an interdisciplinary context prompted health-care providers from all related disciplines to establish the Neuro-Oncology Scientific Club (NOSC) in Iran and let it flourish since 3 years ago. With the advent of advanced technologies and through continued share of experience, NOSC members have tried to provide more integrated diagnoses and therapeutic care to brain tumor patients across the country. NOSC activities revolve around some key tenets including dissemination of education and updates, facilitation of institutional collaborations; data registry and patients' awareness. By virtue of recent insights on molecular characterization of brain tumors such as codeletion of chromosomes 1p and 19q in anaplastic gliomas and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in glioblastoma, a range of translational research is being followed within NOSC. The most recent NOSC meeting which was held in Tehran, recapitulated main advances and dealt with the current debates on functional neurosurgery, biological markers and neuroimaging, risk prediction models in high grade gliomas and clinical issues in pediatric neuro-oncology. This article gives an overview of current hotspots in neuro-oncology research and practice which are pursued within NOSC.

摘要

神经肿瘤学的研究与实践汇集了神经外科、放射肿瘤学、神经放射学、医学肿瘤学、神经病理学及相关学科的临床神经科学专业知识,以优化中枢神经系统恶性肿瘤的治疗规划和治疗方案。这种跨学科背景促使伊朗所有相关学科的医疗服务提供者成立了神经肿瘤学科学俱乐部(NOSC),并且自三年前以来一直蓬勃发展。随着先进技术的出现以及经验的持续分享,NOSC成员一直努力为全国的脑肿瘤患者提供更综合的诊断和治疗护理。NOSC的活动围绕一些关键原则展开,包括教育和最新信息的传播、促进机构间合作、数据登记以及患者宣传。鉴于最近对脑肿瘤分子特征的认识,如间变性胶质瘤中1p和19q染色体的共缺失以及胶质母细胞瘤中O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化,NOSC正在开展一系列转化研究。最近在德黑兰举行的NOSC会议总结了主要进展,并讨论了当前关于功能神经外科、生物标志物和神经影像学、高级别胶质瘤的风险预测模型以及小儿神经肿瘤学临床问题的争论。本文概述了NOSC所开展的神经肿瘤学研究与实践中的当前热点问题。

相似文献

1
An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.伊朗神经肿瘤学研究与实践概述:NOSC倡议实施三年情况
Int J Clin Exp Med. 2015 Mar 15;8(3):3946-55. eCollection 2015.
2
A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.高级别胶质瘤管理的综合方法:伊朗设拉子神经肿瘤科学俱乐部(NOSC)的立场声明
Ger Med Sci. 2017 Feb 28;15:Doc05. doi: 10.3205/000246. eCollection 2017.
3
[Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].[跨学科神经肿瘤学:第1部分:原发性脑肿瘤的诊断与手术治疗]
Nervenarzt. 2014 Aug;85(8):965-75. doi: 10.1007/s00115-014-4041-7.
4
[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].[跨学科神经肿瘤学:第2部分:原发性脑肿瘤的全身治疗]
Nervenarzt. 2014 Aug;85(8):976-81. doi: 10.1007/s00115-014-4122-7.
5
[Chemotherapy of brain tumors in aduts].[成人脑肿瘤的化疗]
Nervenarzt. 2015 Apr;86(4):495-505; quiz 506-7. doi: 10.1007/s00115-014-4242-0.
6
Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.成人间变性(世界卫生组织III级)胶质瘤组织分子亚组的预后意义:应用“综合”诊断方法
J Clin Pathol. 2016 Aug;69(8):686-94. doi: 10.1136/jclinpath-2015-203456. Epub 2016 Jan 7.
7
[Predictive molecular pathological testing in the diagnosis of high-grade tumors of glial origin].[预测性分子病理学检测在胶质源性高级别肿瘤诊断中的应用]
Magy Onkol. 2009 Mar;53(1):33-8. doi: 10.1556/MOnkol.53.2009.1.5.
8
O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.胶质瘤中 O6-甲基鸟嘌呤 DNA 甲基转移酶基因启动子甲基化状态及其与其他分子改变的相关性:首个印度报告,并对其在定制治疗中的应用挑战进行了综述。
Neurosurgery. 2010 Dec;67(6):1681-91. doi: 10.1227/NEU.0b013e3181f743f5.
9
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.间变性和复发性少突胶质细胞瘤中O6-甲基鸟嘌呤DNA甲基转移酶启动子甲基化状态、1p和19q缺失与替莫唑胺反应之间的相关性:一项前瞻性GICNO研究
J Clin Oncol. 2006 Oct 10;24(29):4746-53. doi: 10.1200/JCO.2006.06.3891. Epub 2006 Sep 5.
10
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.MGMT 启动子甲基化在脑胶质瘤中的预后或预测价值取决于 IDH1 突变。
Neurology. 2013 Oct 22;81(17):1515-22. doi: 10.1212/WNL.0b013e3182a95680. Epub 2013 Sep 25.

引用本文的文献

1
A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.高级别胶质瘤管理的综合方法:伊朗设拉子神经肿瘤科学俱乐部(NOSC)的立场声明
Ger Med Sci. 2017 Feb 28;15:Doc05. doi: 10.3205/000246. eCollection 2017.

本文引用的文献

1
Awake craniotomy for brain tumor: indications, technique and benefits.脑肿瘤清醒开颅手术:适应证、技术及益处
Expert Rev Neurother. 2014 Dec;14(12):1405-15. doi: 10.1586/14737175.2014.979793. Epub 2014 Nov 21.
2
Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.小儿幕上高级别胶质瘤:韩国小儿神经肿瘤学会的多中心回顾性观察研究
J Neurooncol. 2015 Jan;121(2):413-9. doi: 10.1007/s11060-014-1653-5. Epub 2014 Nov 4.
3
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients.贝伐珠单抗治疗对新诊断的胶质母细胞瘤患者生存和生活质量的影响。
Cancer Manag Res. 2014 Sep 26;6:373-87. doi: 10.2147/CMAR.S39306. eCollection 2014.
4
Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).是时候重新思考那些不可思议之事了:对新诊断的弥漫性脑桥内在型胶质瘤(DIPG)患儿进行 upfront 活检。 (注:这里“upfront biopsy”可能是医学上一种特定活检方式,具体准确含义需结合医学背景进一步明确,单从翻译角度直接保留英文表述。)
Pediatr Blood Cancer. 2015 Jan;62(1):3-4. doi: 10.1002/pbc.25266. Epub 2014 Oct 4.
5
Bevacizumab and other targeted agents in the upfront treatment of glioblastoma.贝伐单抗及其他靶向药物在胶质母细胞瘤一线治疗中的应用
Semin Radiat Oncol. 2014 Oct;24(4):273-8. doi: 10.1016/j.semradonc.2014.06.002.
6
The genetic signatures of pediatric high-grade glioma: no longer a one-act play.小儿高级别胶质瘤的基因特征:不再是独角戏。
Semin Radiat Oncol. 2014 Oct;24(4):240-7. doi: 10.1016/j.semradonc.2014.06.003.
7
Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation.治疗初发胶质母细胞瘤和间变少突胶质细胞瘤中的新型 MSH6 突变独立于 MGMT 启动子甲基化导致替莫唑胺耐药。
Clin Cancer Res. 2014 Sep 15;20(18):4894-903. doi: 10.1158/1078-0432.CCR-13-1856. Epub 2014 Jul 30.
8
[Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].[跨学科神经肿瘤学:第1部分:原发性脑肿瘤的诊断与手术治疗]
Nervenarzt. 2014 Aug;85(8):965-75. doi: 10.1007/s00115-014-4041-7.
9
The correlation between MR diffusion-weighted imaging and pathological grades on glioma.磁共振扩散加权成像与胶质瘤病理分级之间的相关性。
Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1904-9.
10
Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target.关于贝伐单抗在胶质母细胞瘤中最佳使用的问题:一个不断变化的目标。
Neuro Oncol. 2014 Jun;16(6):765-7. doi: 10.1093/neuonc/nou092.